ISRG · NASDAQ · STOCK
Intuitive Surgical (ISRG) Stock Analysis
$390.24
52W $328.57 – $603.88
63/100
$139.37B
44.6
1.46
Is ISRG Bullish or Bearish?
Bullish.
Innellis AI committee rates Intuitive Surgical (ISRG) Buy with a composite score of 63/100
, based on 6 analysts with 67% agreement.
Last updated August 17, 2026.
What Would Change This View
- Upgrade to Strong Buy
- Requires a committee score of 75.0 — +11.51 from today. Applies on the first day at or above the line; upgrades are never dampened.
- Downgrade to Watch
- Requires the score to fall below 55.0 — -8.49 from today. The band boundary is 60.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.
Executive Summary
Positive signals support the current rating — vix regime is low -- calm backdrop supports risk-taking. The committee sees sufficient evidence to maintain the constructive view.
Bull & Bear Case
Bull Case
- ROE of 17.8% shows genuine earnings power backing the valuation — Value
- 5 consecutive earnings beats -- consistent execution — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- MACD histogram positive -- bullish momentum — Technical
- Low leverage (debt-to-equity 0.00) -- balance sheet can absorb a shock — Risk
- VIX regime is low -- calm backdrop supports risk-taking — Macro
Bear Case
- P/E of 45.2 is expensive by classic value standards — Value
- Price-to-book of 11.3x prices in significant intangible value — Value
- Bollinger bandwidth of 24.0% signals elevated volatility — Risk
Both cases are generated from quantitative data signals, not qualitative or
forward-looking judgement. They summarise what the numbers say today.
Price History (6M)
AI Investment Committee
Committee Consensus
As of August 17, 2026
Overall Committee Score
63/100
Agreement
67%
Analysts
6
Conviction
Moderate
Sector Rank
Top 25%
of 192 Healthcare peers
Value Analyst
neutral
49
/ 100 · High confidence
Fair value -- neither a bargain nor obviously overpriced
+ ROE of 17.8% shows genuine earnings power backing the valuation
− P/E of 45.2 is expensive by classic value standards
Growth Analyst
bullish
77
/ 100 · High confidence
Strong, accelerating growth with consistent execution
+ 5 consecutive earnings beats -- consistent execution
Technical Analyst
neutral
58
/ 100 · High confidence
Mixed or range-bound price action
+ MACD histogram positive -- bullish momentum
Risk Analyst
neutral
58
/ 100 · Moderate confidence
Moderate risk -- no single red flag, but nothing that clearly de-risks the position either
+ Low leverage (debt-to-equity 0.00) -- balance sheet can absorb a shock
− Bollinger bandwidth of 24.0% signals elevated volatility
Macro Analyst
bullish
80
/ 100 · Low confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
+ VIX regime is low -- calm backdrop supports risk-taking
News Analyst
neutral
60
/ 100 · Low confidence
News flow is mixed or quiet -- no strong signal either way right now
Portfolio Manager
neutral
45
/ 100 · High confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− Sector concentration is already high (HHI 2963.04)
Investment Thesis Evolution
Committee score moved marginally from 63.5 to 63.5.
- New bearish signals: 1 appeared.
- Bearish pressure eased: 1 signal(s) disappeared.
Analyst-level changes:
- Portfolio Manager: +1 bearish signal(s).
Comparing 2026-08-16 to 2026-08-17 (1 day apart).
Technical Analysis
RSI (14)
62.6
Neutral
MACD Histogram
6.227
Bullish Momentum
Trend Direction
Sideways
Weekly: Downtrend
Market Structure
Lh Ll
Bollinger %B
0.80
Inside Bands
Price vs Moving Averages
EMA 9
$388.58
Above
EMA 21
$381.89
Above
EMA 50
$392.86
Below
EMA 200
$448.76
Below
Fundamental Analysis
Valuation
17
Growth
93
Profitability
95
Financial Health
100
Cash Flow
70
Valuation
P/E Ratio
44.6×
P/B Ratio
7.70×
PEG Ratio
2.10
Dividend Yield
0.00%
52W High
$603.88
52W Low
$328.57
Quality & Growth
ROE
1602.3%
ROA
1384.3%
Gross Margin
6667.9%
Operating Margin
3127.7%
Revenue Growth YoY
—
Debt / Equity
0.00
AI Fundamental Assessment
P/E ratio of 44.6 (rich relative to a 15-40x range); Price-to-book of 7.7x; PEG ratio of 2.1 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 16.0%; Return on assets of 13.8%; Net margin of 28.4%; Gross margin of 66.7%; Current ratio of 4.96 (healthy short-term liquidity); Debt-to-equity of 0.00; Free cash flow per share is positive (9.09); Most recent quarter beat estimates by 9.8%; 5 consecutive earnings beats; EPS growth accelerating (-1.2% -> +12.0% QoQ); Average YoY EPS growth of 27.9%; Analyst estimates rising over recent quarters
Get the Full ISRG Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →